| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/26/2023 | 76.47% | HC Wainwright & Co. | → $12 | Assumes | → Buy |
What is the target price for Elicio Therapeutics (ELTX)?
The latest price target for Elicio Therapeutics (NASDAQ: ELTX) was reported by HC Wainwright & Co. on October 26, 2023. The analyst firm set a price target for $12.00 expecting ELTX to rise to within 12 months (a possible 76.47% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Elicio Therapeutics (ELTX)?
The latest analyst rating for Elicio Therapeutics (NASDAQ: ELTX) was provided by HC Wainwright & Co., and Elicio Therapeutics their buy rating.
When is the next analyst rating going to be posted or updated for Elicio Therapeutics (ELTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Elicio Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Elicio Therapeutics was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.
Is the Analyst Rating Elicio Therapeutics (ELTX) correct?
While ratings are subjective and will change, the latest Elicio Therapeutics (ELTX) rating was a with a price target of $0.00 to $12.00. The current price Elicio Therapeutics (ELTX) is trading at is $6.80, which is within the analyst's predicted range.